Answers are grounded in this paper and cite their sources.
Demonstrates that intracoronary delivery of mitochondria protects ischemic myocardium in swine, suggesting a safe and effective strategy for reperfusion injury.
Mitochondrial dysfunction is the determinant insult of ischemia-reperfusion injury. Autologous mitochondrial transplantation involves supplying one's healthy mitochondria to the ischemic region harboring damaged mitochondria. The authors used in vivo swine to show that mitochondrial transplantation in the heart by intracoronary delivery is safe, with specific distribution to the heart, and results in significant increase in coronary blood flow, which requires intact mitochondrial viability, adenosine triphosphate production, and, in part, the activation of vascular KIR channels. Intracoronary mitochondrial delivery after temporary regional ischemia significantly improved myocardial function, perfusion, and infarct size. The authors concluded that intracoronary delivery of mitochondria is safe and efficacious therapy for myocardial ischemia-reperfusion injury.
No takes yet. Share an insight, caveat, or question.
Shin et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: